Pitch Training
Pitch Training
This session will offer the opportunity to present your pitch infront of our feedback panel 1 week ahead of pitching at Global Investor Forum. All start-ups that are pitching on 2 April 2025 had the possibilty to attend the Global Investor Forum Pitch Training online on Tuesday, 17 March 2026,
from 13:30 to 17:00 (CET).
Attending the pitch training is a valuable extra to your Global Investor Forum experience and will not only prepare you for your pitch during the actual Global Investor Forum, but for every future pitch you will present!
Meet your trainer & feedback Panel
Giuseppe Marzio | Founder | Chiaro
Strategic Storytelling
Pitch trainer & Feedback panel
Giuseppe has been instrumental in raising hundreds of millions in funding, closing high-value deals, and taking organizations to the next level. His book Winners Have a Story was published in 2022 and became an international Amazon bestseller.
Read more on Chiaro.nl
About Chiaro
Success starts with a great story, in business as in life. Because stories get attention. They get remembered. They change perceptions. Today’s most successful entrepreneurs are those who excel at sharing inspiring stories about their product, company, and vision.
But what does it take to craft a good story?
In this session, you will learn how to apply the basic principles of storytelling to pitch a winning story – to raise funding, grow a successful business, and make the world a healthier place.
Irene Verheijen | Founding Partner |
Flying Turtle Ventures
Feedback panel
Irene Verheijen is Founding Partner and General Partner at Flying Turtle Ventures (FTV). She is a clinical microbiologist+MBA turned investor with over 20 years of experience across life sciences, healthcare, pharma, and medtech. Prior to founding FTV, Irene worked at Pfizer and held operational roles in the medtech industry besides advising various healthcare startups from Imperial College London.
She also
serves as a jury member for MedTech Innovator, DxPx, and Health Innovation
Summit (HIS) and other notable medtech/biotech conferences, and supports due
diligence from various investor networks.
Combining deep scientific expertise with hands-on industry and investment
experience, Irene partners closely with founders and co-investors who share the
ambition to accelerate innovation in traditionally slow-moving healthcare
markets—bringing rigor, speed, and global perspective to company building.
About Flying Turtle Ventures
Flying Turtle Ventures (FTV) is a venture capital firm focused on backing world-class migrant scientific founders in Europe who are addressing critical unmet medical needs through breakthrough medtech and biotech innovation.
Formed by scientists, clinicians, pharma executives, and entrepreneurs, FTV believes that medtech and biotech are key to shaping the future of global healthcare. Beyond capital, the fund provides hands-on support through deep domain expertise, operational insight, and access to an international network. We invest at the early stage, typically from pre-seed through Series A, and co-invests alongside venture capital funds, corporate venture arms, and family offices, aiming to generate both strong financial returns and meaningful societal impact.
Christina Takke | Managing Parnter | V-Bio Ventures
Feedback panel
Christina Takke co-founded V-Bio Ventures in 2015 and has since been a Managing Partner of the firm.
Before launching V-Bio Ventures, Christina spent over 15 years in European Venture Capital, as consultant, analyst and investment manager. In her last position Christina was a partner at Forbion Capital Partners, were she led and managed a series of successful investments in biopharmaceutical and pharmaceutical companies.
Christina has a scientific background, holding a PhD in Developmental Biology from the University of Cologne, Germany, and an MSc in Biology from the University of Darmstadt, Germany.
About V-Bio Ventures
V-Bio Ventures helps build exceptional companies by leveraging great science and empowering talented entrepreneurs.
We are a life science Venture Capital fund that co-creates startups and invests in early- to mid-stage companies with high growth potential. V-Bio helps transform scientific innovation into products that positively impact people’s lives.
Our extensive network and expertise in the sector allow us to contribute more than just capital. We aim at being part of the DNA of the new ventures that we back.
We have a preferred relationship with the Belgium-based VIB, one of the world’s premier life science research institutes. Part of the companies we co-create are built on VIB-derived innovations. We additionally source deals coming from any research institute, entrepreneurial initiative, or spin-outs from mature companies, with a geographical focus on Europe.
Pitching packages
The pitch training is included for all pitching start-ups at Global Investor Forum
Start-up Pitching Slot
- Pitching slot (5 minutes) on 25 March 2026 to present your company.
- Possibility to schedule 1-on-1 meetings with investors on 26 March 2026.
- Possibility to be selected as finalist for the start-up pitch session at I4H on 26 March 2026.
- Your pitch communicated via the website, newsletter and social media.
- 1 conference ticket (for your speaker) for 25-26 March.
- Video recording of your pitch, published on our website and BiotechNEWS & Life Science magazine
Regular fee € 797
Start-up Spotlight Package
All items in Start-up Pitching Package.
- Table-Top stand (1 x 1m) at the Start-up Street on the exhibition floor at Innovation for Health op 26 March 2026.
Your publication (1 column, max 300 words + 1 photo + 1 logo) in the BiotechNEWS & Life Sciences magazine.
Regular fee € 1,675
Sponsors 2026
| Powered by: Hyphen Projects | Connect | Join Global Investor Forum | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
REGISTER NOW
SUBSCRIBE TO OUR NEWSLETTER
|
© Copyright 2025 by Hyphen Projects